Shanghai, China

Yunlei Shi

This inventor holds 2 USPTO granted patents and 2 published patent applications and 6 EPO patents. Top assignee: Shanghai Microport Medbot (Group) Co., Ltd.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yunlei Shi. Retrieved from https://idiyas.com/inventor/yunlei-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yunlei Shi: Pioneering Inventor from Shanghai

Introduction: Yunlei Shi is a distinguished inventor hailing from Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yunlei Shi holds several patents in the areas of artificial intelligence, robotics, and renewable energy, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Yunlei Shi has worked with leading tech companies and research institutions, consistently pushing the boundaries of what is possible in the realm of technological advancements.

Collaborations: Throughout his career, Yunlei Shi has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and knowledge-sharing in his projects.

Conclusion: Yunlei Shi's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of inventions, inspiring the next generation of inventors to dream big and think outside the box.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…